[ORGANIZATION]
Eisai
Featured in 4 tracked stories · first seen
Situations
Leqembi Alzheimer's treatment availability and application
2 clusters · 4 sources · last updated
Latest: Pohang Semyung Christianity Hospital reports first patient to complete 18-month Leqembi treatment
The Alzheimer’s disease medication Leqembi, a monoclonal antibody designed to target amyloid-beta plaques, has seen expanded availability and clinical application. In the United States, Eisai announced the availability
Also covered in
-
NHS drug access: Enhertu approved while lecanemab denied
[HEALTH] · 6 sources ·
-
Dayvigo insomnia medication to launch in Brazil
[HEALTH] · 4 sources ·
-
BioArctic to release Q2 2026 financial report on August 26
[BUSINESS] · 2 sources ·